Abramson Cancer Center of the University of Pennsylvania ( Site 0309) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.
Abramson Cancer Center of the University of Pennsylvania ( Site 0309) has participated in 1 clinical trials.
Therapeutic areas: Hematopoietic Stem Cell Transplantation, Acute Graft Versus Host Disease, Acute Myeloid Leukemia.
Sponsors: Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center of the University of Pennsylvania ( Site 0309) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center of the University of Pennsylvania ( Site 0309) has 1 clinical trials on record. Their work covers Hematopoietic Stem Cell Transplantation, Acute Graft Versus Host Disease, Acute Myeloid Leukemia.
Abramson Cancer Center of the University of Pennsylvania ( Site 0309) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.